Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Labrie

Showing results (481-490 of 723) with videos related to

Pageof 73
Sort By:
Biochemical and Biophysical Research Communications|November 17, 1975
LH-releasing activity of potent LH-RH analogs in vitroD H Coy, F Labrie, M Savary, et al.
Biochemical and Biophysical Research Communications|June 6, 1977
Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropinC Auclair, P A Kelly, F Labrie, et al.
Journal of Medicinal Chemistry|June 23, 1999
Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiolL C Ciobanu, R P Boivin, V Luu-The, et al.
Molecular and Cellular Endocrinology|July 1, 1994
Formation and degradation of dihydrotestosterone by recombinant members of the rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase familyR Sanchez, Y de Launoit, F Durocher, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 14, 2007
Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal womenF Labrie, A Bélanger, C Labrie, et al.
Advances in Experimental Medicine and Biology|January 1, 1977
Mechanism of action of luteinizing hormone releasing hormone and thyrotropin releasing hormone in the anterior pituitary gland and modulation of their activity by peripheral hormonesF Labrie, J Drouin, A De Léan, et al.
Cancer Research|January 1, 1977
High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumorsP A Kelly, J Asselin, M G Caron, et al.
Journal of Steroid Biochemistry|May 1, 1979
Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH)J Asselin, R Mélançon, Y Gourdeau, et al.
Journal of Steroid Biochemistry|July 1, 1983
Multiple factors involved in the control of ACTH and alpha-MSH secretionL Proulx-Ferland, H Meunier, J Côté, et al.
Journal of Medicinal Chemistry|April 28, 1995
Synthesis and in vitro evaluation of 4-substituted N-(1,1-dimethylethyl)-3-oxo-4-androstene-17 beta-carboxamides as 5 alpha-reductase inhibitors and antiandrogensX Li, S M Singh, J Côté, et al.
Pageof 73

Showing results (481-490 of 723) with videos related to

Sort By:
Pageof 73
Biochemical and Biophysical Research Communications|November 17, 1975
LH-releasing activity of potent LH-RH analogs in vitroD H Coy, F Labrie, M Savary, et al.
Biochemical and Biophysical Research Communications|June 6, 1977
Inhibition of testicular luteinizing hormone receptor level by treatment with a potent luteinizing hormone-releasing hormone agonist of human chorionic gonadotropinC Auclair, P A Kelly, F Labrie, et al.
Journal of Medicinal Chemistry|June 23, 1999
Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiolL C Ciobanu, R P Boivin, V Luu-The, et al.
Molecular and Cellular Endocrinology|July 1, 1994
Formation and degradation of dihydrotestosterone by recombinant members of the rat 3 beta-hydroxysteroid dehydrogenase/delta 5-delta 4 isomerase familyR Sanchez, Y de Launoit, F Durocher, et al.
The Journal of Steroid Biochemistry and Molecular Biology|July 14, 2007
Bioavailability and metabolism of oral and percutaneous dehydroepiandrosterone in postmenopausal womenF Labrie, A Bélanger, C Labrie, et al.
Advances in Experimental Medicine and Biology|January 1, 1977
Mechanism of action of luteinizing hormone releasing hormone and thyrotropin releasing hormone in the anterior pituitary gland and modulation of their activity by peripheral hormonesF Labrie, J Drouin, A De Léan, et al.
Cancer Research|January 1, 1977
High inhibitory activity of a new antiestrogen, RU 16117 (11alpha-methoxy ethinyl estradiol), on the development of dimethylbenz(a)anthracene-induced mammary tumorsP A Kelly, J Asselin, M G Caron, et al.
Journal of Steroid Biochemistry|May 1, 1979
Specific binding of [3H]-methyltrienolone to both progestin and androgen binding components in human benign prostatic hypertrophy (BPH)J Asselin, R Mélançon, Y Gourdeau, et al.
Journal of Steroid Biochemistry|July 1, 1983
Multiple factors involved in the control of ACTH and alpha-MSH secretionL Proulx-Ferland, H Meunier, J Côté, et al.
Journal of Medicinal Chemistry|April 28, 1995
Synthesis and in vitro evaluation of 4-substituted N-(1,1-dimethylethyl)-3-oxo-4-androstene-17 beta-carboxamides as 5 alpha-reductase inhibitors and antiandrogensX Li, S M Singh, J Côté, et al.
Pageof 73